[SCHEDULE 13G] RxSight, Inc. SEC Filing
Artisan Partners reports beneficial ownership of 2,252,544 shares of RxSight common stock, representing 5.5% of the class based on 40,636,981 shares outstanding as stated in the filing. The reporting group discloses no sole voting or dispositive power and instead reports 2,041,668 shares with shared voting power and 2,252,544 shares with shared dispositive power.
The shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership and the filers certify the holdings are in the ordinary course of business and not held to influence control. A Joint Filing Agreement among the reporting persons is included as an exhibit.
Artisan Partners dichiara la proprietà beneficiaria di 2,252,544 azioni del capitale ordinario di RxSight, pari al 5,5% della categoria sulla base di 40,636,981 azioni in circolazione, come indicato nel deposito. Il gruppo dichiarante segnala assenza di potere esclusivo di voto o di disposizione e riporta invece 2,041,668 azioni con potere di voto condiviso e 2,252,544 azioni con potere di disposizione condiviso.
Le azioni sono state acquisite per conto di clienti discrezionali di Artisan Partners Limited Partnership e i firmatari certificano che le partecipazioni sono detenute nell'ordinaria attività d'impresa e non per influenzare il controllo. Un Accordo di Presentazione Congiunta tra i soggetti che presentano la dichiarazione è incluso come allegato.
Artisan Partners informa la propiedad beneficiaria de 2,252,544 acciones ordinarias de RxSight, que representan el 5,5% de la clase sobre la base de 40,636,981 acciones en circulación según consta en la presentación. El grupo informante declara no tener poder exclusivo de voto ni de disposición y, en su lugar, reporta 2,041,668 acciones con poder de voto compartido y 2,252,544 acciones con poder de disposición compartido.
Las acciones fueron adquiridas en nombre de clientes discrecionales de Artisan Partners Limited Partnership y los declarante certifican que las participaciones se mantienen en el curso ordinario del negocio y no para influir en el control. Se incluye como anexo un Acuerdo de Presentación Conjunta entre las personas que informan.
Artisan Partners는 RxSight 보통주 2,252,544주에 대한 수익적 소유권을 보고했으며, 이는 제출서류에 기재된 발행주식수 40,636,981주를 기준으로 해당 종류의 5.5%에 해당합니다. 보고 그룹은 단독 의결권 또는 처분권을 보유하지 않음을 밝히고, 대신 공동 의결권이 있는 2,041,668주와 공동 처분권이 있는 2,252,544주를 보고합니다.
해당 주식은 Artisan Partners Limited Partnership의 재량적 고객을 대신하여 취득되었으며, 제출인들은 보유가 영업의 통상적인 범위 내에 있으며 지배에 영향을 미치기 위한 것이 아님을 증명합니다. 보고인들 간의 공동 제출 계약이 증빙 서류로 첨부되어 있습니다.
Artisan Partners déclare la propriété bénéficiaire de 2,252,544 actions ordinaires de RxSight, représentant 5,5% de la catégorie sur la base de 40,636,981 actions en circulation, selon le dépôt. Le groupe déclarant indique ne détenir aucun pouvoir exclusif de vote ou de disposition et déclare plutôt 2,041,668 actions avec pouvoir de vote partagé et 2,252,544 actions avec pouvoir de disposition partagé.
Les actions ont été acquises pour le compte de clients discrétionnaires d'Artisan Partners Limited Partnership et les déclarants certifient que les participations sont détenues dans le cours normal des affaires et non en vue d'influencer le contrôle. Un accord de dépôt conjoint entre les personnes déclarantes est joint en annexe.
Artisan Partners meldet wirtschaftliches Eigentum an 2,252,544 Aktien der Stammaktien von RxSight, was gemäß der Einreichung 5,5% der Klasse auf Basis von 40,636,981 ausstehenden Aktien entspricht. Die meldende Gruppe gibt an, keine alleinige Stimm- oder Verfügungsbefugnis zu besitzen und meldet stattdessen 2,041,668 Aktien mit geteilter Stimmrechtsbefugnis sowie 2,252,544 Aktien mit geteilter Verfügungsbefugnis.
Die Aktien wurden im Namen diskretionärer Kunden von Artisan Partners Limited Partnership erworben, und die Einreicher bestätigen, dass die Bestände im normalen Geschäftsverkehr gehalten werden und nicht dazu dienen, die Kontrolle zu beeinflussen. Eine gemeinsame Einreichungsvereinbarung der meldenden Personen ist als Anhang beigefügt.
- Material institutional position reported: Aggregate beneficial ownership of 2,252,544 shares (5.5% of class) is disclosed.
- Clear disclosure of powers: Filing provides a specific breakdown of shared voting (2,041,668) and shared dispositive (2,252,544) power.
- Passive intent certified: Filers state holdings are in the ordinary course of business and not to influence control.
- No sole control reported: Reporting persons indicate 0 shares of sole voting or sole dispositive power, limiting direct influence on company decisions.
- Held for discretionary clients: Shares are owned on behalf of clients, so no single identified client is disclosed with >5% economic interest.
- Percent based on stated outstanding shares: Ownership percentage (5.5%) is calculated on 40,636,981 shares outstanding as reported in the filing; current outstanding share count may differ.
Insights
TL;DR: Artisan Partners holds a material passive stake of 5.5% (2.25M shares) in RxSight with shared voting/dispositive power.
Artisan Partners reports an aggregate beneficial ownership of 2,252,544 shares, equal to 5.5% of the outstanding common stock (per the filing's stated outstanding share base). The statement is filed on Schedule 13G, and the filers certify the position is held in the ordinary course of business and not to influence control. The breakdown shows 0 sole voting/dispositive power, 2,041,668 shared voting power and 2,252,544 shared dispositive power, indicating economic exposure without unilateral control. For investors, this signals institutional ownership but not an activist/control intent.
TL;DR: A material but passive ownership position is reported; limited ability to change corporate control due to lack of sole power.
The filing documents that the reported shares are held on behalf of discretionary clients of APLP and that no other person known to the filers has an economic interest exceeding 5% of the class. The combination of shared voting power (2,041,668) and shared dispositive power (2,252,544) alongside the Schedule 13G certification suggests the reporting persons view this as a passive investment rather than an attempt to exert governance control. A Joint Filing Agreement is included as an exhibit to coordinate disclosure among the reporting entities.
Artisan Partners dichiara la proprietà beneficiaria di 2,252,544 azioni del capitale ordinario di RxSight, pari al 5,5% della categoria sulla base di 40,636,981 azioni in circolazione, come indicato nel deposito. Il gruppo dichiarante segnala assenza di potere esclusivo di voto o di disposizione e riporta invece 2,041,668 azioni con potere di voto condiviso e 2,252,544 azioni con potere di disposizione condiviso.
Le azioni sono state acquisite per conto di clienti discrezionali di Artisan Partners Limited Partnership e i firmatari certificano che le partecipazioni sono detenute nell'ordinaria attività d'impresa e non per influenzare il controllo. Un Accordo di Presentazione Congiunta tra i soggetti che presentano la dichiarazione è incluso come allegato.
Artisan Partners informa la propiedad beneficiaria de 2,252,544 acciones ordinarias de RxSight, que representan el 5,5% de la clase sobre la base de 40,636,981 acciones en circulación según consta en la presentación. El grupo informante declara no tener poder exclusivo de voto ni de disposición y, en su lugar, reporta 2,041,668 acciones con poder de voto compartido y 2,252,544 acciones con poder de disposición compartido.
Las acciones fueron adquiridas en nombre de clientes discrecionales de Artisan Partners Limited Partnership y los declarante certifican que las participaciones se mantienen en el curso ordinario del negocio y no para influir en el control. Se incluye como anexo un Acuerdo de Presentación Conjunta entre las personas que informan.
Artisan Partners는 RxSight 보통주 2,252,544주에 대한 수익적 소유권을 보고했으며, 이는 제출서류에 기재된 발행주식수 40,636,981주를 기준으로 해당 종류의 5.5%에 해당합니다. 보고 그룹은 단독 의결권 또는 처분권을 보유하지 않음을 밝히고, 대신 공동 의결권이 있는 2,041,668주와 공동 처분권이 있는 2,252,544주를 보고합니다.
해당 주식은 Artisan Partners Limited Partnership의 재량적 고객을 대신하여 취득되었으며, 제출인들은 보유가 영업의 통상적인 범위 내에 있으며 지배에 영향을 미치기 위한 것이 아님을 증명합니다. 보고인들 간의 공동 제출 계약이 증빙 서류로 첨부되어 있습니다.
Artisan Partners déclare la propriété bénéficiaire de 2,252,544 actions ordinaires de RxSight, représentant 5,5% de la catégorie sur la base de 40,636,981 actions en circulation, selon le dépôt. Le groupe déclarant indique ne détenir aucun pouvoir exclusif de vote ou de disposition et déclare plutôt 2,041,668 actions avec pouvoir de vote partagé et 2,252,544 actions avec pouvoir de disposition partagé.
Les actions ont été acquises pour le compte de clients discrétionnaires d'Artisan Partners Limited Partnership et les déclarants certifient que les participations sont détenues dans le cours normal des affaires et non en vue d'influencer le contrôle. Un accord de dépôt conjoint entre les personnes déclarantes est joint en annexe.
Artisan Partners meldet wirtschaftliches Eigentum an 2,252,544 Aktien der Stammaktien von RxSight, was gemäß der Einreichung 5,5% der Klasse auf Basis von 40,636,981 ausstehenden Aktien entspricht. Die meldende Gruppe gibt an, keine alleinige Stimm- oder Verfügungsbefugnis zu besitzen und meldet stattdessen 2,041,668 Aktien mit geteilter Stimmrechtsbefugnis sowie 2,252,544 Aktien mit geteilter Verfügungsbefugnis.
Die Aktien wurden im Namen diskretionärer Kunden von Artisan Partners Limited Partnership erworben, und die Einreicher bestätigen, dass die Bestände im normalen Geschäftsverkehr gehalten werden und nicht dazu dienen, die Kontrolle zu beeinflussen. Eine gemeinsame Einreichungsvereinbarung der meldenden Personen ist als Anhang beigefügt.